Distinct involvement of cAMP-response element-dependent transcriptions in functional and morphological maturation during retinoid-mediated human myeloid differentiation

J Leukoc Biol. 2003 May;73(5):673-81. doi: 10.1189/jlb.1002512.

Abstract

We evaluated the involvement of cyclic adenosine monophosphate-response element (CRE)-dependent transcriptions in all-trans retinoic acid (ATRA)-induced myeloid differentiation using human monoblastic U937 cells. ATRA treatment caused an increment in the CRE-dependent transcription activity and induced a wide variety of differentiation phenotypes including functional and morphological maturation. Indeed, ATRA treatment induced the expression of CCAAT/enhancer-binding protein beta (C/EBPbeta), a CRE-dependent transcription factor important in monocytic differentiation, and the inhibition of CRE-enhancer activity by the expression of a dominant-negative CRE-binding protein (dn-CREB) abolished the induction of C/EBPbeta. Functional maturation, such as the enhancement of cell adhesion and respiratory burst activity, was dramatically suppressed by the expression of dn-CREB. In addition, the differentiation-dependent induction of an adhesion molecule (CD11b), the phagocyte oxidase required for respiratory burst, and the transcription factor PU.1 responsible for phagocyte oxidase induction were all abolished by dn-CREB. Surprisingly, morphological maturation, including nuclear convolution and cytoplasmic vacuolar formation, was augmented by dn-CREB. Under the same conditions, the differentiation-associated cell-growth arrest was not affected by the expression of dn-CREB. Our results clearly indicate that CRE-driven transcription plays at least three distinct roles during myeloid differentiation: It stimulates functional maturation but suppresses morphological maturation and has no effects on cell-growth arrest.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Activating Transcription Factor 2
  • CCAAT-Enhancer-Binding Protein-beta / biosynthesis
  • CCAAT-Enhancer-Binding Protein-beta / genetics
  • CD11b Antigen / biosynthesis
  • CD11b Antigen / genetics
  • Cell Adhesion / physiology
  • Cell Differentiation / drug effects
  • Cell Nucleus / ultrastructure
  • Cyclic AMP / physiology*
  • Cyclic AMP Response Element-Binding Protein / biosynthesis
  • Cyclic AMP Response Element-Binding Protein / genetics
  • Gene Expression Regulation, Neoplastic / drug effects
  • Gene Expression Regulation, Neoplastic / physiology
  • Genes, Dominant
  • Genes, Reporter
  • Humans
  • Intercellular Adhesion Molecule-1 / biosynthesis
  • Intercellular Adhesion Molecule-1 / genetics
  • Myeloid Cells / cytology
  • Myeloid Cells / drug effects*
  • NADPH Oxidases
  • Neoplasm Proteins / biosynthesis
  • Neoplasm Proteins / genetics
  • Phenotype
  • Phosphoproteins / biosynthesis
  • Phosphoproteins / genetics
  • Proto-Oncogene Proteins / biosynthesis
  • Proto-Oncogene Proteins / genetics
  • Regulatory Sequences, Nucleic Acid
  • Respiratory Burst / physiology
  • Second Messenger Systems / drug effects
  • Second Messenger Systems / physiology*
  • Trans-Activators / biosynthesis
  • Trans-Activators / genetics
  • Transcription Factors / biosynthesis
  • Transcription Factors / genetics
  • Transcription, Genetic / drug effects*
  • Transformation, Genetic
  • Tretinoin / pharmacology*
  • U937 Cells / cytology
  • U937 Cells / drug effects
  • Vacuoles / ultrastructure

Substances

  • Activating Transcription Factor 2
  • CCAAT-Enhancer-Binding Protein-beta
  • CD11b Antigen
  • Cyclic AMP Response Element-Binding Protein
  • Neoplasm Proteins
  • Phosphoproteins
  • Proto-Oncogene Proteins
  • Trans-Activators
  • Transcription Factors
  • neutrophil cytosol factor 67K
  • proto-oncogene protein Spi-1
  • Intercellular Adhesion Molecule-1
  • Tretinoin
  • Cyclic AMP
  • NADPH Oxidases
  • neutrophil cytosolic factor 1